Navigation Links
Professor Steven V. Ley Speaks at WuXi PharmaTech
Date:10/7/2010

Professor Steven V. Ley Speaks at WuXi PharmaTech -- SHANGHAI, Oct. 7 /PRNewswire-Asia/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Pharmaceuticals Click to view news release full screen  

Professor Steven V. Ley Speaks at WuXi PharmaTech

 
Download image

SHANGHAI, Oct. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that Dr. Steven V. Ley, BP Professor of Chemistry at the University of Cambridge, visited WuXi AppTec facilities in Shanghai on September 28. He gave a lecture to WuXi scientists titled "New Tools for Synthesis: Enabling Technologies" as part of the WuXi AppTec Science Seminar Series.

(Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO)

Dr. Ley is a world-renowned organic chemist. He founded the Ley Group, which has published extensively on the synthesis of natural products and has synthesized more than 130 target compounds. Dr. Ley's work on iron chemistry, encapsulated reagents, microbial oxidation, spiroketals, and microwave chemistry has been groundbreaking. He has pioneered the use of immobilized reagents in multi-step organic synthesis to make compounds in a cleaner and more effective way. This work now incorporates flow chemistry for multistep organic synthesis applications. He has devised many practical and useful protecting groups using acetal chemistry. He has done significant work in the area of organic catalysis and was one of the inventors of tetrapropylammonium perruthenate (TPAP), a catalytic oxidant that is now used worldwide and cited extensively.

Dr. Ley has published 698 papers to date. His recent awards include the Paracelsus Prize, the Heinrich Wieland Prize, the Tetrahedron Prize, the Perkin Prize for Organic Chemistry, the High Throughput Drug Discovery Methodologies Award, the Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery and the Hans Heroff Inhoffen Medal. In 1990 he was elected to the Royal Society (London) and was President of The Royal Society of Chemistry from 2000-2002. He was named a Commander of the Order of the British Empire (CBE) in January 2002.

"It is an honor to speak at WuXi PharmaTech, which provides high-quality research and development services to the world's leading life science companies," Dr. Ley said. "I was very impressed by WuXi's comprehensive training system and the research capabilities of WuXi scientists."

"We are privileged to have Dr. Ley share his expertise with our scientists," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec. "As we broaden our R&D service scope, our success depends on the quality of our scientists. Investing in people will continue to be our key strategy."

For more information, please contact: Stephanie Liu (for the media) Tel: +86-21-5046-4362 Email: Stephanie_liu@wuxiapptec.com Ronald Aldridge (for investors) Tel: +1-201-585-2048 Email: Ron_Aldridge@wuxiapptec.com
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award
2. NYU-Poly Professor Among First Winners of BioAccelerate NYC Prize; Project May Move Diagnostic Medicine from the Lab to the Palm of a Hand
3. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
4. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
5. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
6. WellSpring Pharmaceutical, American Gastroenterological Association, and Steven Bramson of Humanscale Partner With MediaPlanet to Publish One of the Largest Digestive Wellness Campaigns in U.S. History to Overcome Upset Stomach, Nausea, IBS, and Deb
7. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
8. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
9. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
10. D-M-S Holdings, Inc. Announces the Filing of a Lawsuit Against Veridian Healthcare, LLC, Steven M. Bisulca and Michael Mazza
11. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 21, 2017 Cadence Design Systems, Inc. (NASDAQ: ... Tensilica ® Fusion F1 DSP is part of the ... The licensable IP targets SoCs designed for battery-powered sensor nodes ... leveraged the Fusion F1 DSP both to implement the IEEE ... trigger, audio identification and sensor fusion on a single DSP. ...
(Date:2/21/2017)... and Markets has announced the addition of the "Rosacea Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Rosacea ... market? What are the unit prices and annual treatment ...
(Date:2/20/2017)... , Feb. 21, 2017 Taiwan Biophotonic ... provider of non-invasive vital signs sensing solutions, today announced ... first finger-free wrist pulse oximeter, the oCare TM Pro ... wearable healthcare and medical devices space.  tBPC,s ... provides a non-invasive, simple and reliable method to measure ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... February 21, 2017 , ... ... Medical Clinic in Durant, Oklahoma, on Feb. 21. , The celebration began with ... community members, clinic employees, the construction team and tribal leadership. , Choctaw ...
(Date:2/21/2017)... ... February 21, 2017 , ... Doctors on Liens has announced the addition ... Kendell Mendonca , to its growing network of doctors in Central and Northern California. ... car accidents such as whiplash, back pain, neck pain, hip and knee pain, and ...
(Date:2/21/2017)... Fort Worth, TX (PRWEB) , ... February 21, 2017 , ... ... planning assistance to communities in and around Tarrant County, is embarking on a six ... to research cures and treatments for cancer. , Cancer is one of the deadliest ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... today announced the further expansion of its eHealth App xChange™, providing clinical ... part of Bioclinica’s extensive and growing eHealth platform. Applications that enable patient-centered ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS is ... connected care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, and ... providers have no Health Information Exchange outside of faxing. Medal’s innovative technology “meets ...
Breaking Medicine News(10 mins):